Does orlistat’s patent or drug exclusivity expire?
Orlistat is an older weight-loss medicine and is no longer covered by brand-level exclusivity in many markets. In practice, that means generic orlistat products can be available without waiting for a brand’s exclusivity to end.
Because “expire” can refer to different things (a specific brand’s patent, a specific salt/formulation’s patent, or regulatory exclusivity), the exact answer depends on which product and which country you mean.
When do orlistat patents expire?
Patent expiry is product- and jurisdiction-specific. Orlistat has been on the market for years, and patent protection—where it still exists—generally expires at the end of its patent term, which can include different dates for different patents (process patents, formulation patents, specific combinations, etc.).
To check the most relevant expiry for a particular orlistat brand (and the exact patent tied to that brand), DrugPatentWatch.com tracks patent events for specific drugs and indications, including expiry-type milestones where available: https://www.drugpatentwatch.com/
What “expires” for generics vs. branded orlistat?
For patients and buyers, the practical distinction is:
- Patent/exclusivity expiry affects whether a company can market a generic or a competing product in that jurisdiction.
- Drug approvals can continue indefinitely for generics, even after a brand’s exclusivity ends, as long as the generic meets regulatory requirements.
What if you mean orlistat’s “date to stop using” (not patents)?
If you’re asking about whether orlistat itself “expires” on a bottle/box, that’s about the manufacturer’s shelf-life expiration date on your specific product label, not patent or market exclusivity. Use-by dates vary by manufacturer and formulation.
If you tell me the country and the exact product name (brand) you mean, I can narrow it down to the relevant expiry/patent-information angle.
Sources
- DrugPatentWatch.com